A prospective study of adjuvant CMF in males with node positive breast cancer: 20-Year follow-up

Breast Cancer Research and Treatment

Volumn 103, Issue 2, 2007, Pages 177-183

  Walshe, Janice M ^a   Berman, Arlene W ^a   Vatas, Ujala ^a   Steinberg, Seth M ^a   Anderson, William F ^a   Lippman, Marc E ^b   Swain, Sandra M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Adjuvant chemotherapy; CMF chemotherapy; Male breast cancer

Indexed keywords

CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DIARRHEA; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; FEBRILE NEUTROPENIA; FOLLOW UP; HUMAN; IMPOTENCE; LIBIDO; LYMPH NODE METASTASIS; MALE; MASTECTOMY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; SIDE EFFECT; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS, MALE; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; SEER PROGRAM;

EID: 34249053878     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9363-0     Document Type: Article

References (49)

1. Jemal A, Siegel R, Ward E et al (2006) Cancer statistics, 2006. CA Cancer J Clin 56(2):106-130
2. Giordano SH, Cohen DS, Buzdar AU et al (2004) Breast carcinoma in men: a population-based study. Cancer 101(1):51-57
3. Anderson WF, Devesa SS (2005) In situ male breast carcinoma in the Surveillance, Epidemiology, and End Results database of the National Cancer Institute. Cancer 104(8):1733-1741
4. Wainwright J (1927) Carcinoma of the male breast. Arch Surg 14:836-859
5. Heller KS, Rosen PP, Schottenfeld D et al (1978) Male breast cancer: a clinicopathologic study of 97 cases. Ann Surg 188(1):60-65
6. Ramantanis G, Besbeas S, Garas JG (1980) Breast cancer in the male: a report of 138 cases. World J Surg 4(5):621-623
7. Stierer M, Rosen H, Weitensfelder W et al (1995) Male breast cancer: Austrian experience. World J Surg 19(5):687-692; discussion 692-683
8. Donegan WL, Redlich PN, Lang PJ et al (1998) Carcinoma of the breast in males: a multiinstitutional survey. Cancer 83(3):498-509
9. Erlichman C, Murphy KC, Elhakim T (1984) Male breast cancer: a 13-year review of 89 patients. J Clin Oncol 2(8):903-909
10. Yap HY, Tashima CK, Blumenschein GR et al (1979) Male breast cancer: a natural history study. Cancer 44(2):748-754
11. Salvadori B, Saccozzi R, Manzari A et al (1994) Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer 30A(7):930-935
12. Cutuli B, Lacroze M, Dilhuydy JM et al (1995) Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer 31A(12):1960-1964
13. Guinee VF, Olsson H, Moller T et al (1993) The prognosis of breast cancer in males. A report of 335 cases. Cancer 71(1):154-161
14. Goss PE, Reid C, Pintilie M et al (1999) Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer 85(3):629-639
15. Spence RA, MacKenzie G, Anderson JR et al (1985) Long-term survival following cancer of the male breast in Northern Ireland. A report of 81 cases. Cancer 55(3):648-652
16. Yildirim E, Berberoglu U (1998) Male breast cancer: a 22-year experience. Eur J Surg Oncol 24(6):548-552
17. Ribeiro GG (1977) Carcinoma of the male breast: a review of 200 cases. Br J Surg 64(6):381-383
18. Ribeiro G (1985) Male breast carcinoma-a review of 301 cases from the Christie Hospital & Holt Radium Institute, Manchester. Br J Cancer 51(1):115-119
19. Crichlow RW (1974) Breast cancer in men. Semin Oncol 1(2):145-152
20. Ribeiro G, Swindell R, Harris M et al (1996) A review of the management of the male breast carcinoma based on an analysis of 420 treated cases. Breast 5:141-146
21. Robison R, Montague ED (1982) Treatment results in males with breast cancer. Cancer 49(2):403-406
22. Appelqvist P, Salmo M (1982) Prognosis in carcinoma of the male breast. Acta Chir Scand 148(6):499-502
23. Crichlow RW (1972) Carcinoma of the male breast. Surg Gynecol Obstet 134(6):1011-1019
24. Bonadonna G, Brusamolino E, Valagussa P et al (1976) Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 294(8):405-410
25. Bagley CS, Wesley MN, Young RC et al (1987) Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol 10(1):55-60
26. Beahrs OH, Myers M (eds) (1983) Manual for staging of cancer-american joint committee on cancer. J.B. Lippincott Co., Philadelphia
27. Kaplan E, Meier P (1958) Non-parametric estimation from incomplete observation. J Am Statist Assoc 53:457-481
28. Surveillance, Epidemiology, End results (SEER) Program (www.seer.cancer.gov) SEER STAT database: Incidence- SEER 17 Regs Public-use; November 2005 submission for survival analyses [1973-2003 varying], National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006
29. Patel HZ II, Buzdar AU, Hortobagyi GN (1989) Role of adjuvant chemotherapy in male breast cancer. Cancer 64(8):1583-1585
30. Izquierdo MA, Alonso C, De Andres L et al (1994) Male breast cancer. Report of a series of 50 cases. Acta Oncol 33(7):767-771
31. Giordano SH, Perkins GH, Broglio K et al (2005) Adjuvant systemic therapy for male breast carcinoma. Cancer 104(11):2359-2364
32. Rosenblatt KA, Thomas DB, McTiernan A et al (1991) Breast cancer in men: aspects of familial aggregation. J Natl Cancer Inst 83(12):849-854
33. D'Avanzo B, La Vecchia C (1995) Risk factors for male breast cancer. Br J Cancer 71(6):1359-1362
34. Sasco AJ, Lowenfels AB, Pasker-de Jong P (1993) Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 53(4):538-549
35. Schottenfeld D, Lilienfeld AM, Diamond H (1963) Some observations on the epidemiology of breast cancer among males. Am J Public Health 53:890-897
36. Storm HH, Olsen J (1999) Risk of breast cancer in offspring of male breast-cancer patients. Lancet 353(9148):209
37. Hemminki K, Vaittinen P (1999) Male breast cancer: risk to daughters. Lancet 353(9159):1186-1187
38. Travis LB, Hill DA, Dores GM et al (2003) Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290(4):465-475
39. Auvinen A, Curtis RE, Ron E (2002) Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst 94(17):1330-1332
40. Struewing JP, Brody LC, Erdos MR et al (1995) Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet 57(1):1-7
41. Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62(3):676-689
42. Osorio A, Barroso A, Martinez B et al (2000) Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families. Br J Cancer 82(7):1266-1270
43. Sasano H, Kimura M, Shizawa S et al (1996) Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study. J Clin Endocrinol Metab 81(8):3063-3067
44. Anderson WF, Althuis MD, Brinton LA et al (2004) Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 83(1):77-86
45. Ribeiro G, Swindell R (1992) Adjuvant tamoxifen for male breast cancer (MBC). Br J Cancer 65(2):252-254
46. Nahleh ZA (2006) Hormonal therapy for male breast cancer: a different approach for a different disease. Cancer Treat Rev 32(2):101-105
47. Munoz de Toro MM, Maffini MV, Kass L et al (1998) Proliferative activity and steroid hormone receptor status in male breast carcinoma. J Steroid Biochem Mol Biol 67(4):333-339
48. Weber-Chappuis K, Bieri-Burger S, Hurlimann J (1996) Comparison of prognostic markers detected by immunohistochemistry in male and female breast carcinomas. Eur J Cancer 32A(10):1686-1692
49. http://www.swog.org/Visitors/ViewProtocolDetails.asp?ProtocolID=1995